Industry trade groups ask FDA to “significantly revise” its draft guidance on safety and effectiveness data needed for OTC sunscreen ingredients and produce a “modern version based on advances in toxicological risk assessment.”
“We believe the draft guidance proposes a framework that is not reflective of the current state-of-art in ingredient safety assessment,”...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?